1-3 of 3
Benjamin Esterni, PhD
Close
Sort by
Journal Articles

Comorbidities Index Is Not Predictive of Treatment Related Mortality in Patients (pts) Older Than 60 Years Treated with Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation (RIC-ALLO).

Luca Castagna, MD, Sabine Furst, MD, Jean El Cheikh, MD, Catherine Faucher, MD, Mohamad Mohty, MD, PhD, Benjamin Esterni, PhD, Didier Blaise, MD
Journal: Blood
Blood (2009) 114 (22): 1180.
https://doi.org/10.1182/blood.V114.22.1180.1180
Published: 2009
Journal Articles

Allogeneic Stem Cell Immunotherapy for Advanced Metastatic Breast Cancer: Lessons from Experience

Didier Blaise, MD, Anthony Goncalves, MD, PHD, Sabine Furst, MD, Jacques-Olivier Bay, MD, PHD, Catherine Faucher, MD, Mauricette Michallet, MD, PhD, Reza Tabrizi, MD, Jean-Yves Cahn, MD, PhD, Anne Sirvent, MD, Mohamad Mohty, MD, PhD, Christian Chabannon, MD, PhD, Gwenaelle Gravis, MD, Benjamin Esterni, PHD, Jean-Marc Extra, MD, Patrice Viens, MD
Journal: Blood
Blood (2008) 112 (11): 3903.
https://doi.org/10.1182/blood.V112.11.3903.3903
Published: 2008
Journal Articles

Plasma Proteomic Profiles May Predict Early Acute Graft-vs.-Host Disease (aGVHD) Following Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).

Mohamad Mohty, MD, PhD, Anthony Goncalves, MD,PhD, Benjamin Esterni, PhD, Yves Toiron, Beatrice Gaugler, PhD, Catherine Faucher, MD, Jean El-Cheikh, MD, Sabine Furst, MD, Jean-Albert Gastaut, MD, Patrice Viens, MD, Daniel Olive, MD,PhD, Christian Chabannon, MD,PhD, Jean-Paul Borg, PhD, Didier Blaise, MD
Journal: Blood
Blood (2006) 108 (11): 2880.
https://doi.org/10.1182/blood.V108.11.2880.2880
Published: 2006